Beijing Science Sun Pharmaceutical Co Ltd (300485) - Total Liabilities
Based on the latest financial reports, Beijing Science Sun Pharmaceutical Co Ltd (300485) has total liabilities worth CN¥171.26 Million CNY (≈ $25.06 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Beijing Science Sun Pharmaceutical Co Lt annual equity growth to track the company's year-over-year net asset growth rate.
Beijing Science Sun Pharmaceutical Co Ltd - Total Liabilities Trend (2011–2024)
This chart illustrates how Beijing Science Sun Pharmaceutical Co Ltd's total liabilities have evolved over time, based on quarterly financial data. See 300485 free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Beijing Science Sun Pharmaceutical Co Ltd Competitors by Total Liabilities
The table below lists competitors of Beijing Science Sun Pharmaceutical Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Zhejiang JW Precision Machinery Co.Ltd
SHE:300984
|
China | CN¥610.60 Million |
|
Arvind Fashions Limited
NSE:ARVINDFASN
|
India | Rs30.55 Billion |
|
Gansu Yatai Industrial Development Co Ltd
SHE:000691
|
China | CN¥548.96 Million |
|
Guangdong Mingzhu Group Co Ltd
SHG:600382
|
China | CN¥580.64 Million |
|
Patrizia AG
XETRA:PAT
|
Germany | €620.27 Million |
|
Guangdong Enpack Packaging Co Ltd
SHE:002846
|
China | CN¥2.38 Billion |
|
Mama's Creations Inc.
NASDAQ:MAMA
|
USA | $12.31 Million |
|
Ta Ann Holdings Bhd
KLSE:5012
|
Malaysia | RM691.13 Million |
Liability Composition Analysis (2011–2024)
This chart breaks down Beijing Science Sun Pharmaceutical Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Beijing Science Sun Pharmaceutical Co Lt market cap and net worth.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 21.80 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.05 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.05 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Beijing Science Sun Pharmaceutical Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Beijing Science Sun Pharmaceutical Co Ltd (2011–2024)
The table below shows the annual total liabilities of Beijing Science Sun Pharmaceutical Co Ltd from 2011 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CN¥166.48 Million ≈ $24.36 Million |
+7.68% |
| 2023-12-31 | CN¥154.61 Million ≈ $22.62 Million |
-1.58% |
| 2022-12-31 | CN¥157.10 Million ≈ $22.99 Million |
+32.52% |
| 2021-12-31 | CN¥118.54 Million ≈ $17.35 Million |
-16.00% |
| 2020-12-31 | CN¥141.13 Million ≈ $20.65 Million |
+49.73% |
| 2019-12-31 | CN¥94.26 Million ≈ $13.79 Million |
-54.04% |
| 2018-12-31 | CN¥205.07 Million ≈ $30.01 Million |
+53.14% |
| 2017-12-31 | CN¥133.91 Million ≈ $19.60 Million |
+12.88% |
| 2016-12-31 | CN¥118.63 Million ≈ $17.36 Million |
+91.34% |
| 2015-12-31 | CN¥62.00 Million ≈ $9.07 Million |
-13.54% |
| 2014-12-31 | CN¥71.71 Million ≈ $10.49 Million |
+51.51% |
| 2013-12-31 | CN¥47.33 Million ≈ $6.93 Million |
+34.56% |
| 2012-12-31 | CN¥35.18 Million ≈ $5.15 Million |
+8.59% |
| 2011-12-31 | CN¥32.39 Million ≈ $4.74 Million |
-- |
About Beijing Science Sun Pharmaceutical Co Ltd
Beijing Science Sun Pharmaceutical Co., Ltd., a biopharmaceutical company, engages in the research, development, production, and sale of injections in China. The company offers products for cardiovascular, cerebrovascular, immunomodulation, and nervous systems, among others. It is also involved in the research, development, production, and sale of raw materials; the extraction of traditional Chin… Read more